Literature DB >> 29954474

Human papillomavirus prevalence and clinicopathological associations in oropharyngeal squamous cell carcinoma in the Lebanese population.

R Mhawej1, C Ghorra2, S Naderi2, N Khoueir1, W Abou Hamad1, A E Melkane1.   

Abstract

OBJECTIVES: To evaluate for the first time the prevalence of human papillomavirus in oropharyngeal squamous cell carcinoma in a Middle-Eastern population, and to determine associations between human papillomavirus profiles and clinicopathological characteristics.
METHODS: A retrospective chart review was conducted of all patients treated for oropharyngeal squamous cell carcinoma at the Hotel Dieu de France University Hospital (Beirut, Lebanon) between January 2010 and 2016. Existing formalin-fixed paraffin-embedded tumour samples were analysed. Human papillomavirus DNA viral load and p16 expression were evaluated using polymerase chain reaction and immunohistochemistry respectively.
RESULTS: Thirty patients (mean age of 60 years) were included. Twenty-seven per cent of patients were p16-positive/human papillomavirus DNA positive, 53 per cent were p16-negative/human papillomavirus DNA negative and 20 per cent were p16-positive/human papillomavirus DNA negative. Human papillomavirus 16 was the most frequent subtype (75 per cent). Smoking and alcohol consumption were significantly lower in the human papillomavirus positive group compared to the human papillomavirus negative group (p = 0.049 and 0.004, respectively).
CONCLUSION: Human papillomavirus rate was lower than reported rates in Western populations. Possible explanations include differences in social and cultural behaviours.

Entities:  

Keywords:  Head and Neck Cancer; Human Papilloma Virus; Middle-East; Oropharynx; Prevalence; Squamous Cell Carcinoma

Mesh:

Substances:

Year:  2018        PMID: 29954474     DOI: 10.1017/S0022215118001019

Source DB:  PubMed          Journal:  J Laryngol Otol        ISSN: 0022-2151            Impact factor:   1.469


  1 in total

1.  HPV-related oropharyngeal cancer prevalence in a middle eastern population using E6/E7 PCR.

Authors:  Ibrahim Khalifeh; Roger V Moukarbel; Christopher A Maroun; Karine Al Feghali; Henri Traboulsi; Helene Dabbous; Fatmeh Abbas; Gabriel Dunya; Georges Ziade; Rami Mahfouz; Bassem Youssef; Hani Tamim; Fady Geara
Journal:  Infect Agent Cancer       Date:  2020-01-06       Impact factor: 2.965

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.